• Please log in or register to access this feature.

Review

You have free access to this content

New issues in the pathogenesis of hepatocellular carcinoma: Applying insights from next-generation DNA sequencing technologies to improve therapy for hepatocellular carcinoma†

  1. Roongruedee Chaiteerakij M.D.1,
  2. Lewis R. Roberts M.B. Ch.B., Ph.D.2,*

Article first published online: 23 JAN 2013

DOI: 10.1002/cld.113

Issue

Clinical Liver Disease

Clinical Liver Disease

Special Issue: Current Issues in Hepatocellular Carcinoma

Volume 1, Issue 6, pages 200–205, December 2012

Additional Information

How to Cite

Chaiteerakij, R. and Roberts, L. R. (2012), New issues in the pathogenesis of hepatocellular carcinoma: Applying insights from next-generation DNA sequencing technologies to improve therapy for hepatocellular carcinoma. Clinical Liver Disease, 1: 200–205. doi: 10.1002/cld.113

Author Information

  1. 1

    Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, MN

  2. 2

    Department of Medicine, Faculty of Medicine, Chulalongkorn University/King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand

*Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 23 JAN 2013
  2. Article first published online: 23 JAN 2013
  3. Manuscript Accepted: 16 OCT 2012
  4. Manuscript Received: 6 SEP 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (563K)

REFERENCES

  • 1
    Totoki Y, Tatsuno K, Yamamoto S, Arai Y, Hosoda F, Ishikawa S, et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 2011; 43: 464–469.
  • 2
    Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011; 43: 828–829.
  • 3
    Tao Y, Ruan J, Yeh SH, Lu X, Wang Y, Zhai W, et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A 2011; 108: 12042–12047.
  • 4
    Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44: 760–764.
  • 5
    Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694–698.
  • 6
    Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet 2012; 44: 1117–1121.
  • 7
    Ferber M, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC, et al. Integration of the hepatitis B virus (HBV) and human papilloma virus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 2003; 22: 3813–3820.
  • 8
    Paterlini-Bréchot P, Saigo K, Murakami Y, Chami M, Gozuacik D, Mugnier C, et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 2003; 22: 3911–3916.
View Full Article (HTML) Get PDF (563K)